NSC |
Compound |
Enrichment |
Correlation |
NSC 668261 |
Null |
0.0415729612483931 |
0.40855109 |
NSC 70931 |
2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo- |
0.0430505868034758 |
0.21048888 |
NSC 736202 |
Indenoisoquinoline derivative |
0.0430505868034758 |
-0.038432866 |
NSC 86373 |
Quinolinium, 4-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1-methyl- iodide |
0.0430505868034758 |
0.056336698 |
NSC 106486 |
Formycin B |
0.0430505868034761 |
0.094087506 |
NSC 107043 |
Null |
0.0430505868034761 |
0.16385043 |
NSC 114340 |
Ophiobolin A |
0.0430505868034761 |
0.15429919 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0430505868034761 |
0.16561041 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0430505868034761 |
0.2079473 |
NSC 135073 |
WITHACNISTIN |
0.0430505868034761 |
0.30141499 |